Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000996

Drug Information
NameSotrastaurin acetate
CompanyNovartis
IndicationHttp://clinicaltrials.gov/ct2/show/NCT01064791?term=Sotrastaurin&rank=1Phase II    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C25H22N6O2.C2H4O2/c1-30-10-12-31(13-11-30)25-27-19-9-5-3-7-16(
19)22(28-25)21-20(23(32)29-24(21)33)17-14-26-18-8-4-2-6-15(17)18;
1-2(3)4/h2-9,14,26H,10-13H2,1H3,(H,29,32,33);1H3,(H,3,4)
InChIKeyRVEUYBMXVVDLFO-UHFFFAOYSA-N
Canonical SMILESCC(=O)O.CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=
C65    
CAS NumberCAS 908351-31-5
PubChem Compound IDCID 24779745.
ClinicalTrials.govNCT01064791;
TargetProtein Kinase C beta typeInhibitor[1]
Protein Kinase C beta typeMultitarget[1]
Protein kinase C alpha typeInhibitor[1]
Protein kinase C alpha typeMultitarget[1]
Protein kinase C theta typeInhibitor[1]
Protein kinase C theta typeMultitarget[1]
Ref 1Emerging drugs for psoriasis. Expert Opin Emerg Drugs. 2009 Mar;14(1):145-63. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543